Micoy Therapeutics
Company profile on P2PMarketData. Micoy Therapeutics is a biotechnology company based in Brooklyn, NY, founded in 2024. Profile with funding rounds, SEC filings and financials.
Micoy Therapeutics is a biotechnology company based in Brooklyn, New York, developing therapeutics and diagnostics that target harmful autoantibodies. Its lead programs address autoantibodies against Type I Interferons, which weaken antiviral immunity, and against Folate Receptor alpha, linked to infertility. The company is developing decoy biologics designed to neutralize these autoantibodies and a blood test designed to detect them.
Frequently asked questions about Micoy Therapeutics
Is Micoy Therapeutics profitable?
No. Micoy Therapeutics reported a net loss of $1.5M for fiscal year 2023.
How many employees does Micoy Therapeutics have?
Micoy Therapeutics reported 4 employees for fiscal year 2023.
When was Micoy Therapeutics founded?
Micoy Therapeutics was founded in June 2024.
Where is Micoy Therapeutics based?
Micoy Therapeutics is headquartered in Brooklyn, New York, United States, and is incorporated in Delaware, United States.
What industry is Micoy Therapeutics in?
Micoy Therapeutics operates in the Biotechnology industry within the Healthcare sector.